Robert M. Infarinato - 11 Sep 2024 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
VP, CFO
Signature
/s/ Robert M. Infarinato
Issuer symbol
PHIO
Transactions as of
11 Sep 2024
Net transactions value
$0
Form type
4
Filing time
13 Sep 2024, 15:00:20 UTC
Previous filing
15 Aug 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common Stock, $0.0001 Par Value Award $0 +3,000 +38% $0.000000 11,000 11 Sep 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares underlying a restricted stock unit, which shares will vest in one year on the first anniversary.
F2 Includes shares of common stock underlying unvested restricted stock units.